Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$16,768,367
+$2,228,102 QoQ
Shares Held
66,025
+11.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#822
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. JNJ ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,768,367 | 66,025 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $14,540,265 | 59,484 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $11,558,981 | 55,854 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $10,122,631 | 54,593 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $7,901,297 | 51,727 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $9,791,191 | 59,040 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $8,366,698 | 57,853 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $9,138,886 | 56,392 | Shares | Other | 2024-10-23 | |
| 2024-06-30 | $7,617,711 | 52,119 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $8,293,425 | 52,427 | Shares | Other | 2024-04-11 | |
| 2023-12-31 | $7,014,583 | 44,753 | Shares | Other | 2024-01-23 | |
| 2023-09-30 | $7,451,856 | 47,845 | Shares | Other | 2023-10-19 | |
| 2023-06-30 | $8,381,434 | 50,637 | Shares | Other | 2023-07-26 | |
| 2023-03-31 | $5,537,840 | 35,728 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $7,263,845 | 41,120 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $5,945,486 | 36,395 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $5,719,016 | 32,218 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $5,789,749 | 32,668 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $4,680,131 | 27,358 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $3,874,383 | 23,990 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $3,960,842 | 24,043 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $3,726,470 | 22,674 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $3,488,641 | 22,167 | Shares | Other | 2021-01-25 | |
| 2020-09-30 | $3,703,686 | 24,877 | Shares | Other | 2020-10-22 | |
| 2020-06-30 | $3,586,343 | 25,502 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $3,284,149 | 25,045 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||